Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,889 | -2,527 | -10,446 | -8,102 | -3,775 |
| Depreciation Amortization | 42 | 16 | 54 | 31 | 20 |
| Accounts receivable | -7 | -2 | -35 | -36 | -37 |
| Other Working Capital | -259 | -216 | -352 | -455 | -197 |
| Other Operating Activity | 2,415 | 1,328 | 4,647 | 4,014 | 1,365 |
| Operating Cash Flow | $-2,698 | $-1,402 | $-6,132 | $-4,549 | $-2,624 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -2 | -118 | -67 | -19 |
| Other Investing Activity | 0 | 0 | 271 | 0 | 0 |
| Investing Cash Flow | $-2 | $-2 | $153 | $-67 | $-19 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 132 | 127 | 337 | 338 | 138 |
| Debt Repayment | -12 | -6 | -21 | -15 | -12 |
| Common Stock Issued | 897 | N/A | 7,939 | 7,899 | 2,320 |
| Other Financing Activity | -91 | -51 | -409 | -395 | -155 |
| Financing Cash Flow | $925 | $70 | $7,847 | $7,827 | $2,292 |
| Beginning Cash Position | 2,304 | 2,304 | 437 | 437 | 437 |
| End Cash Position | 529 | 970 | 2,304 | 3,649 | 85 |
| Net Cash Flow | $-1,775 | $-1,335 | $1,868 | $3,212 | $-351 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,698 | -1,402 | -6,132 | -4,549 | -2,624 |
| Capital Expenditure | -2 | -2 | -118 | -67 | -19 |
| Free Cash Flow | -2,701 | -1,404 | -6,250 | -4,615 | -2,643 |